Integrated CDMO Services

Our discovery services focus on enabling molecular innovation during the earliest stages of drug research. Through advanced synthetic chemistry and a diverse library of functional molecular building blocks, we help researchers rapidly explore novel chemical space and generate high-quality compounds for biological evaluation. This stage emphasizes creativity and feasibility exploration, supporting the discovery of new molecular structures for emerging therapeutic modalities such as targeted protein degradation, drug delivery ligands, and bioconjugation components.

Our process development platform transforms laboratory-scale chemistry into robust, scalable, and cost-effective manufacturing processes. Using advanced tools such as Design of Experiments (DoE), impurity profiling, and process modeling, we systematically optimize reaction conditions, improve yields, and enhance process robustness. Special expertise is applied to complex chemistries involved in bioconjugation linkers, radiopharmaceutical chelators, and heterocyclic or metal-containing compounds. The result is a well-characterized process ready for technology transfer, scale-up, and clinical or commercial manufacturing.

Our custom synthesis services deliver high-quality solutions for complex molecules, rare intermediates, and high-value compounds supporting modern pharmaceutical research and development. Backed by strong expertise in synthetic chemistry and scalable process design, we enable the efficient preparation of key components across multiple advanced therapeutic modalities, including drug delivery systems such as LNP and GalNAc, bioconjugation elements like ADC linkers, radiopharmaceutical chelators including DOTA and NOTA, and targeted protein degradation molecules such as PROTACs and molecular glues. In addition, we provide a diverse portfolio of functional molecular building blocks, covering heterocyclic compounds, nitrogen compounds, sulfur and selenium compounds, phosphorus compounds, metal complexes, and other specialized organic molecules, ensuring reliable access to critical materials that accelerate innovative drug discovery.

Our manufacturing capabilities support the reliable production of drug substances and key intermediates from clinical supply to commercial scale. Operating under stringent quality and regulatory standards, our facilities enable multi-step synthesis, handling of complex chemistries, and scalable production of advanced pharmaceutical materials. From kilogram-scale pilot production to large-scale manufacturing, we ensure consistent quality, secure supply chains, and efficient delivery of critical materials for pharmaceutical and biotech partners worldwide.

Our analytical development platform ensures product quality, process understanding, and regulatory compliance throughout the drug development lifecycle. We provide comprehensive analytical services including method development, method validation, impurity characterization, structural elucidation, stability studies, and release testing. Supported by advanced analytical technologies such as HPLC, LC-MS, NMR, and spectroscopy, our analytical teams deliver robust data packages that support process development, quality control, and global regulatory submissions.